发明名称 |
Anti-bacterial vaccine compositions |
摘要 |
<p>An attenuated Pasteurellaceae bacteria comprising a mutation in a gene having a nucleotide sequence set forth in SEQ ID NO:76 is described. The mutation results in decreased yiaO biological activity of a gene product encoded by the mutated gene, wherein the decreased yiaO biological activity attenuates the bacteria. Also described are vaccine compositions comprising the bacteria, isolated polynucleotides and polypeptides, vectors, non-human host cells, antibodies and methods for producing a gram-negative mutant. A method of identifying an anti-bacterial agent comprises the steps of assaying potential agents for the ability to interfere with expression or activity of a yiaO gene product, represented by the amino acid sequence set forth in SEQ ID NO: 77, and identifying an agent that interferes with yiaO gene expression or biological activity of the gene product. (62) Divided out of 514883</p> |
申请公布号 |
NZ530012(A) |
申请公布日期 |
2005.10.28 |
申请号 |
NZ20000530012 |
申请日期 |
2000.04.06 |
申请人 |
PHARMACIA & UPJOHN COMPANY LLC |
发明人 |
LOWERY, DAVID E;FULLER, TROY E;KENNEDY, MICHAEL J |
分类号 |
G01N33/50;A61K35/74;A61K39/02;A61K39/102;A61K39/395;A61P31/04;C07K14/285;C07K16/12;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/01;C12N15/09;C12N15/31;C12N15/63;C12P21/02;C12P21/08;C12Q1/18;G01N33/15;G01N33/53;G01N33/569;G01N33/577;(IPC1-7):C12N1/21 |
主分类号 |
G01N33/50 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|